Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -1.68% | -0.38% | -41.38% |
12:24pm | Aurinia Pharmaceuticals Inc. Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis | CI |
03/06 | Lucien Selce Sends Letter to Aurinia shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.38% | 75Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.4TCr | |
+2.59% | 2.26TCr | |
-10.09% | 1.82TCr | |
-40.52% | 1.68TCr | |
-14.00% | 1.62TCr | |
+1.18% | 1.34TCr | |
+24.18% | 1.13TCr |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Insider Sell: Aurinia Pharmaceuticals